The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocality
Abstract
BACKGROUND: It is known that patients with papillary microcarcinoma (PMC) of the thyroid gland have a very favorable prognosis. The rising incidence of PMC among papillary thyroid carcinoma (PTC) necessitates the identification of prognostic factors and the formulation of treatment protocols. METHODS: The authors conducted a retrospective analysis of 203 patients with PMC who were diagnosed on or before 1999 and were treated at the Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong. RESULTS: The cause specific survival, locoregional (LR) failure free survival, and distant metastases failure free survival rates at 10 years were 100%, 92.1%, and 97.1%, respectively. Five patients had lung metastases; 2 patients died of their metastases 12.9 years and 14.8 years after diagnosis, and 3 patients achieved clinical remission after radioiodine (RAI) treatment. Twelve patients had LR recurrences. Patients with LR recurrence were highly salvageable with a combination of surgery, RAI treatment, and external radiotherapy; all but one (who refused treatment) were alive without disease at last follow‐up. Multivariate analyses did not reveal any independent prognostic factor for survival. The risk of cervical lymph node (LN) recurrence increased 6.2‐fold (P = 0.01) and 5.6‐fold (P = 0.02) when LN metastases and multifocal disease were present at diagnosis. RAI ablation reduced the LN recurrence rate to 0.27 (P = 0.04). The presence of LN metastasis increased the rate of distant metastasis 11.2‐fold (P = 0.03). Age was not a significant factor in predicting disease recurrence or survival. Subdivision by tumor sizes ≤ 5 mm and > 5 mm did not affect the outcome, but no patient with tumors ≤ 5 mm had mortality related to PMC. CONCLUSIONS: Despite the overall excellent prognosis for patients with PMC, PMC was associated with a 1.0% disease‐related mortality rate, a 5.0% LN recurrence rate, and a 2.5% distant metastasis rate. Therefore, the treatment of patients with PMC should be no different from the treatment of patients with conventional PTC: i.e., complete surgery with consideration for RAI and/or external radiation therapy if poor prognostic factors are present. Cancer 2003;98:31–40. © 2003 American Cancer Society. DOI 10.1002/cncr.11442
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
American Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
Mazzaferri, E. L., & Jhiang, S. M. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90321-2 · Cited by 2,635
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
Mazzaferri, E. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.4.1447 · Cited by 1,396
HAY, I. D., Bergstralh, E. J., Goellner, J. R., Ebersold, J. R., & Grant, C. S. (1993) · PubMed · Cited by 1,223
Natural History, Treatment, and Course of Papillary Thyroid Carcinoma*
DEGROOT, L. J., KAPLAN, E. L., MCCORMICK, M., & STRAUS, F. H. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-2-414 · Cited by 1,049
Occult papillary carcinoma of the thyroid. A “normal” finding in finland. A systematic autopsy study
Harach, H. R., Franssila, K. O., & Wasenius, V.-M. (1985) · Cancer · doi:10.1002/1097-0142(19850801)56:3<531::aid-cncr2820560321>3.0.co;2-3 · Cited by 945
Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period
Hay, I. D., Hutchinson, M. E., Gonzalez-Losada, T., McIver, B., Reinalda, M. E., Grant, C. S., Thompson, G. B., Sebo, T. J., & Goellner, J. R. (2008) · Surgery · doi:10.1016/j.surg.2008.08.035 · Cited by 940
Hay, I. D., Thompson, G. B., Grant, C. S., Bergstralh, E. J., Dvorak, C. E., Gorman, C. A., Maurer, M. S., McIver, B., Mullan, B. P., Oberg, A. L., et al. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6612-1 · Cited by 736
Samaan, N. A. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.3.714 · Cited by 615
Long-term results and prognostic factors in patients with differentiated thyroid carcinoma
Tubiana, M., Schlumberger, M., Rougier, P., Laplanche, A., Benhamou, E., Gardet, P., Caillou, B., Travagli, J.-P., & Parmentier, C. (1985) · Cancer · doi:10.1002/1097-0142(19850215)55:4<794::aid-cncr2820550418>3.0.co;2-z · Cited by 573
Schlumberger, M. J., Vathaire, C. C.-D., de Vathaire, F., Travagli, J. P., Gardet, P., Lumbroso, J., Francese, C., Fontaine, F., Ricard, M., & Parmentier, C. (1996) · PubMed · Cited by 498
Loh, K.-C. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.11.3553 · Cited by 396
Tsang, R. W., Brierley, J. D., Simpson, W. J., Panzarella, T., Gospodarowicz, M. K., & Sutcliffe, S. B. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980115)82:2<389::aid-cncr19>3.0.co;2-v · Cited by 381
Geographic pathology of occult thyroid carcinomas
Fukunaga, F. H., & Yatani, R. (1975) · Cancer · doi:10.1002/1097-0142(197509)36:3<1095::aid-cncr2820360338>3.0.co;2-9 · Cited by 295
Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma
Qubain, S. W., Nakano, S., Baba, M., Takao, S., & Aikou, T. (2002) · Surgery · doi:10.1067/msy.2002.120657 · Cited by 249
HAY, I. D., McConahey, W. M., & Goellner, J. R. (2002) · PubMed · Cited by 224
Casara, D., Rubello, D., Saladini, G., Masarotto, G., Favero, A., Girelli, M. E., & Busnardo, B. (1993) · PubMed · Cited by 212
SUGITANI, I., & FUJIMOTO, Y. (1999) · Endocrine Journal · doi:10.1507/endocrj.46.209 · Cited by 170
Yamashita, H., Noguchi, S., Murakami, N., Toda, M., Yamashita, H., Uchino, S., Watanabe, S., & Kawamoto, H. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990901)86:5<842::aid-cncr21>3.0.co;2-x · Cited by 169
Fink, A. K., TOMLINSON, G. A., Freeman, J. L., Rosen, I. B., & Asa, S. L. (1996) · PubMed · Cited by 109
Sugitani, I., Yanagisawa, A., Shimizu, A., Kato, M., & Fujimoto, Y. (1998) · World Journal of Surgery · doi:10.1007/s002689900461 · Cited by 85
Outcome after treatment of papillary thyroid microcarcinoma.
Appetecchia, M., Scarcello, G., Pucci, E., & Procaccini, A. (2002) · PubMed · Cited by 78
Chung, W. Y., Chang, H., Kim, E., et al. (2001) · Surgery Today · doi:10.1007/s005950170044 · Cited by 45
The Current Surgical Approach to Non-Medullary Thyroid Cancer
Gimm, O., & Dralle, H. (2001) · Springer eBooks · doi:10.1007/978-3-662-04610-4_5 · Cited by 4
Caraceni (1998) · doi:10.1002/(sici)1097-0142(19980801)83:3
Cited by
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Sherman, S. I., & Tuttle, R. M. (2006) · Thyroid · doi:10.1089/thy.2006.16.109 · Cited by 2,016
Guidelines for the management of thyroid cancer
Perros, P., Boelaert, K., Colley, S., Evans, C., Evans, R. M., Gerrard BA, G., Gilbert, J., Harrison, B., Johnson, S. J., Giles, T. E., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12515 · Cited by 1,372
BRAF mutation in thyroid cancer
Xing, M. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.0978 · Cited by 1,300
Metadata
- Authors
- Chow, S., Law, S. C. K., Chan, J. K. C., Au, S., Yau, S., & Lau, W.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2003-05-20
- Volume
- 98
- Issue
- 1
- Pages
- 31-40
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2149487804
- Cited by
- 723
- References
- 28
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.